156 related articles for article (PubMed ID: 10727847)
1. Alpha-fetoprotein-derived antiestrotrophic octapeptide.
Mesfin FB; Bennett JA; Jacobson HI; Zhu S; Andersen TT
Biochim Biophys Acta; 2000 Apr; 1501(1):33-43. PubMed ID: 10727847
[TBL] [Abstract][Full Text] [Related]
2. The recombinant third domain of human alpha-fetoprotein retains the antiestrotrophic activity found in the full-length molecule.
Festin SM; Bennett JA; Fletcher PW; Jacobson HI; Shaye DD; Andersen TT
Biochim Biophys Acta; 1999 Apr; 1427(2):307-14. PubMed ID: 10216247
[TBL] [Abstract][Full Text] [Related]
3. Computational design and experimental discovery of an antiestrogenic peptide derived from alpha-fetoprotein.
Kirschner KN; Lexa KW; Salisburg AM; Alser KA; Joseph L; Andersen TT; Bennett JA; Jacobson HI; Shields GC
J Am Chem Soc; 2007 May; 129(19):6263-8. PubMed ID: 17441722
[TBL] [Abstract][Full Text] [Related]
4. Antiestrogenic and anticancer activities of peptides derived from the active site of alpha-fetoprotein.
Joseph LC; Bennett JA; Kirschner KN; Shields GC; Hughes J; Lostritto N; Jacobson HI; Andersen TT
J Pept Sci; 2009 Apr; 15(4):319-25. PubMed ID: 19189271
[TBL] [Abstract][Full Text] [Related]
5. A peptide derived from alpha-fetoprotein prevents the growth of estrogen-dependent human breast cancers sensitive and resistant to tamoxifen.
Bennett JA; Mesfin FB; Andersen TT; Gierthy JF; Jacobson HI
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):2211-5. PubMed ID: 11830647
[TBL] [Abstract][Full Text] [Related]
6. Development of a synthetic cyclized peptide derived from alpha-fetoprotein that prevents the growth of human breast cancer.
Mesfin FB; Andersen TT; Jacobson HI; Zhu S; Bennett JA
J Pept Res; 2001 Sep; 58(3):246-56. PubMed ID: 11576331
[TBL] [Abstract][Full Text] [Related]
7. Synthetic peptide derived from alpha-fetoprotein inhibits growth of human breast cancer: investigation of the pharmacophore and synthesis optimization.
DeFreest LA; Mesfin FB; Joseph L; McLeod DJ; Stallmer A; Reddy S; Balulad SS; Jacobson HI; Andersen TT; Bennett JA
J Pept Res; 2004 May; 63(5):409-19. PubMed ID: 15140158
[TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein derived synthetic peptides: assay of an estrogen-modifying regulatory segment.
Mizejewski GJ; Dias JA; Hauer CR; Henrikson KP; Gierthy J
Mol Cell Endocrinol; 1996 Apr; 118(1-2):15-23. PubMed ID: 8735587
[TBL] [Abstract][Full Text] [Related]
9. Estradiol-activated alpha-fetoprotein suppresses the uterotropic response to estrogens.
Mizejewski GJ; Vonnegut M; Jacobson HI
Proc Natl Acad Sci U S A; 1983 May; 80(9):2733-7. PubMed ID: 6189129
[TBL] [Abstract][Full Text] [Related]
10. Separation of the estrogen-activated growth-regulatory forms of alpha-fetoprotein in mouse amniotic fluid.
Mizejewski GJ; Keenan JF; Setty RP
Biol Reprod; 1990; 42(5-6):887-98. PubMed ID: 1696509
[TBL] [Abstract][Full Text] [Related]
11. Human alpha-fetoprotein peptides bind estrogen receptor and estradiol, and suppress breast cancer.
Vakharia D; Mizejewski GJ
Breast Cancer Res Treat; 2000 Sep; 63(1):41-52. PubMed ID: 11079158
[TBL] [Abstract][Full Text] [Related]
12. Review and proposed action of alpha-fetoprotein growth inhibitory peptides as estrogen and cytoskeleton-associated factors.
Mizejewski G; Smith G; Butterstein G
Cell Biol Int; 2004; 28(12):913-33. PubMed ID: 15566961
[TBL] [Abstract][Full Text] [Related]
13. Alpha-fetoprotein derived from a human hepatoma prevents growth of estrogen-dependent human breast cancer xenografts.
Bennett JA; Zhu S; Pagano-Mirarchi A; Kellom TA; Jacobson HI
Clin Cancer Res; 1998 Nov; 4(11):2877-84. PubMed ID: 9829755
[TBL] [Abstract][Full Text] [Related]
14. A new antiestrogen, 2-(4-hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol hydrochloride (ERA-923), inhibits the growth of tamoxifen-sensitive and -resistant tumors and is devoid of uterotropic effects in mice and rats.
Greenberger LM; Annable T; Collins KI; Komm BS; Lyttle CR; Miller CP; Satyaswaroop PG; Zhang Y; Frost P
Clin Cancer Res; 2001 Oct; 7(10):3166-77. PubMed ID: 11595711
[TBL] [Abstract][Full Text] [Related]
15. The alpha-fetoprotein-derived growth inhibitory peptide 8-mer fragment: review of a novel anticancer agent.
Mizejewski GJ
Cancer Biother Radiopharm; 2007 Feb; 22(1):73-98. PubMed ID: 17627416
[TBL] [Abstract][Full Text] [Related]
16. Studies of the intrinsic antiuterotropic activity of murine alpha-fetoprotein.
Mizejewski GJ; Vonnegut M; Jacobson HI
Tumour Biol; 1986; 7(1):19-36. PubMed ID: 2428091
[TBL] [Abstract][Full Text] [Related]
17. Survey of functional activities of alpha-fetoprotein derived growth inhibitory peptides: review and prospects.
Mizejewskia GJ; Butterstein G
Curr Protein Pept Sci; 2006 Feb; 7(1):73-100. PubMed ID: 16472170
[TBL] [Abstract][Full Text] [Related]
18. Studies on a growth-inhibitory peptide derived from alpha-fetoprotein and some analogs.
Eisele LE; Mesfin FB; Bennett JA; Andersen TT; Jacobson HI; Soldwedel H; MacColl R; Mizejewski GJ
J Pept Res; 2001 Jan; 57(1):29-38. PubMed ID: 11168886
[TBL] [Abstract][Full Text] [Related]
19. Alpha-fetoprotein growth inhibitory peptides: potential leads for cancer therapeutics.
Mizejewski GJ; MacColl R
Mol Cancer Ther; 2003 Nov; 2(11):1243-55. PubMed ID: 14617798
[TBL] [Abstract][Full Text] [Related]
20. Structural analysis of α-fetoprotein (AFP)-like peptides with anti-breast-cancer properties.
Temelso B; Alser KA; Gauthier A; Palmer AK; Shields GC
J Phys Chem B; 2014 May; 118(17):4514-26. PubMed ID: 24702603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]